Correlation Between Adagene and C4 Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Adagene and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adagene and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adagene and C4 Therapeutics, you can compare the effects of market volatilities on Adagene and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adagene with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adagene and C4 Therapeutics.

Diversification Opportunities for Adagene and C4 Therapeutics

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Adagene and CCCC is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Adagene and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Adagene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adagene are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Adagene i.e., Adagene and C4 Therapeutics go up and down completely randomly.

Pair Corralation between Adagene and C4 Therapeutics

Given the investment horizon of 90 days Adagene is expected to generate 1.13 times more return on investment than C4 Therapeutics. However, Adagene is 1.13 times more volatile than C4 Therapeutics. It trades about 0.03 of its potential returns per unit of risk. C4 Therapeutics is currently generating about -0.11 per unit of risk. If you would invest  212.00  in Adagene on September 18, 2024 and sell it today you would lose (2.00) from holding Adagene or give up 0.94% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Adagene  vs.  C4 Therapeutics

 Performance 
       Timeline  
Adagene 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Adagene are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, Adagene may actually be approaching a critical reversion point that can send shares even higher in January 2025.
C4 Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days C4 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Adagene and C4 Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Adagene and C4 Therapeutics

The main advantage of trading using opposite Adagene and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adagene position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.
The idea behind Adagene and C4 Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon